Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin

NCT03671538 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Non-squamous Non-small Cell Lung Cancer

Interventions

DRUG: Anlotinib
DRUG: pemetrexed
DRUG: Cisplatin

Sponsor

Lingyu Luo